(Q33989952)

English

Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (A

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (A (English)

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

circulatory system

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1

object named as

Björn Dahlöf

0 references

object named as

Mark Caulfield

6

0 references

Sverre E. Kjeldsen

8

object named as

Sverre E Kjeldsen

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

author name string

Peter S Sever

2

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Neil R Poulter

3

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Hans Wedel

4

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

D Gareth Beevers

5

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Rory Collins

7

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Arni Kristinsson

9

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Gordon T McInnes

10

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Jesper Mehlsen

11

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Markku Nieminen

12

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Eoin O'Brien

13

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Jan Ostergren

14

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

ASCOT Investigators

15

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

language of work or name

0 references

publication date

1 September 2005

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

366

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

9489

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

895-906

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Selected major risk factors and global and regional burden of disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967185-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967185-1

7 January 2021

based on heuristic

inferred from DOI database lookup

2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967185-1

7 January 2021

based on heuristic

inferred from DOI database lookup

The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure<SUBTITLE>The JNC 7 Report</SUBTITLE>

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967185-1

7 January 2021

based on heuristic

inferred from DOI database lookup

2003 World Health Organization (WHO)/International Society of Hypertension (ISH) statement on management of hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967185-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Guidelines for management of hypertension: report of the fourth working party of the British Hypertension Society, 2004-BHS IV.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967185-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967185-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Blood pressure screening, management and control in England

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967185-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Should calcium antagonists be first-line agents in the treatment of cardiovascular disease? The public health perspective

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967185-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Systolic Hypertension in Europe (Syst-Eur) Trial Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967185-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Rationale, design, methods and baseline demography of participants of the Anglo-Scandinavian Cardiac Outcomes Trial. ASCOT investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967185-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Prospective randomized open blinded end-point (PROBE) study. A novel design for intervention trials. Prospective Randomized Open Blinded End-Point

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967185-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial--Lipid Lowering Arm (ASCOT-LLA): a multicentre ra

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967185-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Secondary crisis in African health care

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967185-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Systolic and diastolic blood pressure control in antihypertensive drug trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967185-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967185-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Angiotensin-Converting Enzyme Inhibitors and Calcium Channel Blockers for Coronary Heart Disease and Stroke Prevention

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967185-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967185-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Role of blood pressure and other variables in the differential cardiovascular event rates noted in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA).

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967185-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Hypertension and antihypertensive therapy as risk factors for type 2 diabetes mellitus. Atherosclerosis Risk in Communities Study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967185-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Old antihypertensives and new diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967185-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Adverse prognostic significance of new diabetes in treated hypertensive subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967185-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Atenolol in hypertension: is it a wise choice?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967185-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Principal Results of the Controlled Onset Verapamil Investigation of Cardiovascular End Points (CONVINCE) Trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967185-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Morbidity and mortality in patients randomised to double-blind treatment with a long-acting calcium-channel blocker or diuretic in the International Nifedipine GITS study: Intervention as a Goal in Hypertension Treatment (INSIGHT).

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967185-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomised trial of effects of calcium antagonists compared with diuretics and beta-blockers on cardiovascular morbidity and mortality in hypertension: the Nordic Diltiazem (NORDIL) study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967185-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Calcium antagonist lacidipine slows down progression of asymptomatic carotid atherosclerosis: principal results of the European Lacidipine Study on Atherosclerosis (ELSA), a randomized, double-blind, long-term trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967185-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0140-6736(05)67185-1

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33989952&oldid=1532181379"